Prostaglandins Use Before Mirena IUD Insertion in Prev CS Women During Lactational Amenorrhea

Last updated: January 15, 2021
Sponsor: Cairo University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Amenorrhea

Treatment

N/A

Clinical Study ID

NCT04646161
professor
  • Ages 20-45
  • Female
  • Accepts Healthy Volunteers

Study Summary

This is a prospective randomized controlled study to determine the effect of prostaglandin intake before Mirena IUD insertion It was conducted at the Department of Obstetrics & Gynecology, Kasr El-Ainy Teaching Hospital, Faculty of Medicine, Cairo University,

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 1- Women in lactational amenoeehea with pregnancy test negative 2- Women who hadcaesarean section within 6 monthes of IUD insertion 3- No medical disorders

Exclusion

Exclusion Criteria:

  • 1- Women in regular menses 2- Medical disorders 3- Nulligravida or muligravida withNVD 4- Women with history of Previous CS more than one CS 5- Any congenital uterineanomalies, fibroids and adenomysis 6- Chronic pelvic pain 7- Intrauterine adhesions 8-Spasmodic dysmenohrrea 9- Allergy to misoprostol

Study Design

Total Participants: 400
Study Start date:
November 25, 2020
Estimated Completion Date:
March 01, 2022

Study Description

The study aiming to measure the estimate difficulty of insertion of the Mirena IUD by using prostaglandins 2 hours before the procedure and the effect of prostaglandins to make this procedure easy with other side effects and complications as bleeding perforation, nausea, vomiting, failure of insertion and comparing them with a placebo group who didn't receive prostaglandins

Connect with a study center

  • Cairo University

    Cairo, 02
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.